(Q50564697)

English

Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014.

scientific article published on 14 April 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25882170

Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25882170

0 references

1 reference

based on heuristic

inferred from title

author name string

Whole Mycobacteria Cell Vaccines for Tuberculosis Summary Group

1

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25882170

language of work or name

0 references

publication date

14 April 2015

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25882170

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25882170

33

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25882170

26

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25882170

3047-3055

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25882170

Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Prospects for Tuberculosis Elimination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Diagnosis of childhood tuberculosis and host RNA expression in Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Recent advances towards tuberculosis control: vaccines and biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Recombinant live vaccine candidates against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

From bacteriology to immunology: the dualism of specificity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Identification of antigens specific to non-tuberculous mycobacteria: the Mce family of proteins as a target of T cell immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Tuberculosis: from genome to vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

M. tuberculosis and M. leprae Translocate from the Phagolysosome to the Cytosol in Myeloid Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Phagosomal rupture by Mycobacterium tuberculosis results in toxicity and host cell death

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Antigen Load Governs the Differential Priming of CD8 T Cells in Response to the Bacille Calmette Guerin Vaccine or Mycobacterium tuberculosis Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Release of mycobacterial antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

The BCG replacement vaccine VPM1002: from drawing board to clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

PEST sequences and regulation by proteolysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

A PEST-like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Recombinant BCG ΔureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

The recombinant tuberculosis vaccine rBCG ΔureC::hly(+) induces apoptotic vesicles for improved priming of CD4(+) and CD8(+) T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Central memory CD4+ T cells are responsible for the recombinant Bacillus Calmette-Guérin ΔureC::hly vaccine's superior protection against tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Mycobacterium bovis Bacille Calmette-Guérin strains secreting listeriolysin of Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Learning from natural infection for rational tuberculosis vaccine design: from basic science to translational research

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

The second Geneva Consensus: Recommendations for novel live TB vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

PhoP: a missing piece in the intricate puzzle of Mycobacterium tuberculosis virulence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

ESX-1-induced apoptosis is involved in cell-to-cell spread of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

The PhoP-dependent ncRNA Mcr7 modulates the TAT secretion system in Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Protective immunity afforded by attenuated, PhoP-deficient Mycobacterium tuberculosis is associated with sustained generation of CD4+ T-cell memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Safety and Immunogenicity of a Five-Dose Series of Inactivated Mycobacterium vaccae Vaccination for the Prevention of HIV-Associated Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Immunogenicity of an inactivated mycobacterial vaccine for the prevention of HIV-associated tuberculosis: a randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Prevention of tuberculosis in Bacille Calmette-Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Therapeutic vaccines for tuberculosis--a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Granuloma encapsulation is a key factor for containing tuberculosis infection in minipigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Safety, tolerability, and immunogenicity of the novel antituberculous vaccine RUTI: randomized, placebo-controlled phase II clinical trial in patients with latent tuberculosis infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Crystal Structure of Mycobacterium tuberculosis Zinc-dependent Metalloprotease-1 (Zmp1), a Metalloprotease Involved in Pathogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Functional characterization of the Mycobacterium tuberculosis zinc metallopeptidase Zmp1 and identification of potential substrates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Mycobacterium tuberculosis prevents inflammasome activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Relief from Zmp1-mediated arrest of phagosome maturation is associated with facilitated presentation and enhanced immunogenicity of mycobacterial antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

BCG Δzmp1 vaccine induces enhanced antigen specific immune responses in cattle.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

In search of a new paradigm for protective immunity to TB

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

A small jab - a big effect: nonspecific immunomodulation by vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Longitudinal changes in CD4(+) T-cell memory responses induced by BCG vaccination of newborns

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.03.056

7 January 2021

Identifiers

10.1016/J.VACCINE.2015.03.056

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25882170

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/25882170

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50564697&oldid=2070455722"